Lanini, Simone
Milleri, Stefano
Andreano, Emanuele http://orcid.org/0000-0003-0088-5788
Nosari, Sarah
Paciello, Ida
Piccini, Giulia
Gentili, Alessandra http://orcid.org/0000-0002-8646-6287
Phogat, Adhuna
Hyseni, Inesa
Leonardi, Margherita
Torelli, Alessandro http://orcid.org/0000-0003-3629-5149
Montomoli, Emanuele
Paolini, Andrea
Frosini, Andrea
Antinori, Andrea
Nicastri, Emanuele http://orcid.org/0000-0002-5606-8712
Girardi, Enrico
Plazzi, Maria Maddalena
Ippolito, Giuseppe http://orcid.org/0000-0002-1076-2979
Vaia, Francesco
Della Cioppa, Giovanni
Rappuoli, Rino http://orcid.org/0000-0002-8827-254X
Article History
Received: 27 January 2022
Accepted: 7 April 2022
First Online: 27 April 2022
Competing interests
: R.R. is an employee of the GSK group of companies. E.A., I.P., and R.R. are listed as inventors of full-length human monoclonal antibodies described in Italian patent application nos. 102020000015754 filed on 30 June 2020, 102020000018955 filed on 3 August 2020, and 102020000029969 filed on 4 December 2020 and the international patent system number PCT/IB2021/055755 filed on 28 June 2021. All patents were submitted by Fondazione Toscana Life Sciences, Siena, Italy. The remaining authors have no competing interests to declare.